On the recordSeptember 25, 2011
If it doesn't get fixed, we may not see its 4 or 5 years, I am more concerned not about the drugs that are currently in phase 3.
Source
congress.govIf it doesn't get fixed, we may not see its 4 or 5 years, I am more concerned not about the drugs that are currently in phase 3.
Bilbray expresses concern about the future of drug innovation if current issues aren't resolved.
Share
More from Brian Bilbray
I have always worried that experts--what is the line they always say, generals always fight the last war, not the next one.
But that is like saying that the people that are a victim of counterfeit isn't going to be prosecuted as counterfeiters when the fact is they're losing value down the line.
I think that the fact is people are starting to depend on this for more and more, and they want it consolidated.
Mr. Chairman, I think it's only fair to point out that there is so much that the industry can work with...